The Current Ratio as of November 2024 (TTM) for Quantum-Si incorporated (QSI) is 13.42

According to Quantum-Si incorporated’s latest financial reports and current stock price. The company's current Current Ratio is 13.42. This represents a change of -38.73% compared to the average of 21.90 of the last 4 quarters.

Quantum-Si incorporated (QSI) Historical Current Ratio (quarterly & annually)

How has QSI Current Ratio performed in the past?

The mean historical Current Ratio of Quantum-Si incorporated over the last ten years is 23.69. The current 13.42 Current Ratio has changed 5.56% with respect to the historical average. Over the past ten years (40 quarters), QSI's Current Ratio was at its highest in in the September 2021 quarter at 70.21. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Quantum-Si incorporated (QSI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Quantum-Si incorporated Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Quantum-Si incorporated (QSI) Average Current Ratio

How has QSI Current Ratio performed in the past?

The current Current Ratio of Quantum-Si incorporated (QSI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Quantum-Si incorporated (QSI) Current Ratio vs. Peers

How is QSI’s Current Ratio compared to its peers?

Quantum-Si incorporated’s Current Ratio is greater than Nurix Therapeutics, Inc. (5.28), less than Seer, Inc. (18.36), greater than HCW Biologics Inc. (0.07), less than MediciNova, Inc. (16.66), greater than Beam Therapeutics Inc. (5.69), greater than Intellia Therapeutics, Inc. (6.73), greater than Editas Medicine, Inc. (3.75), greater than Verve Therapeutics, Inc. (13.05), greater than Prime Medicine, Inc. (6.50), greater than Passage Bio, Inc. (5.15), greater than Black Diamond Therapeutics, Inc. (5.55), greater than TCR2 Therapeutics Inc. (2.77), greater than Harpoon Therapeutics, Inc. (1.89), greater than Alector, Inc. (3.29), greater than HOOKIPA Pharma Inc. (3.26), greater than Acumen Pharmaceuticals, Inc. (10.43), greater than Heron Therapeutics, Inc. (2.28), greater than Homology Medicines, Inc. (4.19), less than Avidity Biosciences, Inc. (17.76), greater than Caribou Biosciences, Inc. (7.38), less than CRISPR Therapeutics AG (21.64),

Build a custom stock screener for Quantum-Si incorporated (QSI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Quantum-Si incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Quantum-Si incorporated (QSI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Quantum-Si incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.